The scientist’s investigation covers issues in Microbiology, Antibacterial agent, Tigecycline, Efflux and Glycylcycline. Her Microbiology research incorporates themes from Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacteriaceae. The Antibacterial agent study combines topics in areas such as Multiple drug resistance, β lactamases, Antimicrobial, Staphylococcus aureus and Sulbactam.
Patricia A. Bradford has included themes like Mutant, Acinetobacter baumannii, Acinetobacter, Molecular biology and Antibiotic resistance in her Efflux study. The concepts of her Glycylcycline study are interwoven with issues in Ribosomal RNA and A-site. Her Drug resistance study combines topics from a wide range of disciplines, such as Vaborbactam, Avibactam, Bacteria and Enzyme.
Her primary areas of investigation include Microbiology, Antibacterial agent, Tigecycline, Antibiotics and Klebsiella pneumoniae. Her Microbiology study integrates concerns from other disciplines, such as Pseudomonas aeruginosa, Enterobacteriaceae, Escherichia coli and Staphylococcus aureus. Her Antibacterial agent study incorporates themes from Antimicrobial, Mutant, Vancomycin, Glycopeptide and Sulbactam.
The study incorporates disciplines such as Minocycline, Efflux, Colistin and Etest in addition to Tigecycline. As part of one scientific family, she deals mainly with the area of Antibiotics, narrowing it down to issues related to the Piperacillin, and often Pharmacology. Her Klebsiella pneumoniae research includes elements of Ciprofloxacin, Imipenem, Enterobacter, Ceftazidime and Drug resistance.
Patricia A. Bradford mainly focuses on Microbiology, Klebsiella pneumoniae, Broth microdilution, Ceftazidime/avibactam and Pseudomonas aeruginosa. Patricia A. Bradford combines subjects such as Enterococcus faecalis, Enterobacteriaceae and Acinetobacter baumannii with her study of Microbiology. The Klebsiella pneumoniae study which covers Plasmid that intersects with Genome.
Her Broth microdilution study also includes
Patricia A. Bradford focuses on Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, Avibactam and Clade. Her Microbiology research incorporates elements of Research center and Health innovation. Her studies in Klebsiella pneumoniae integrate themes in fields like Healthcare associated infections and Epidemiology.
Her research integrates issues of Broth microdilution, Antibiotic resistance and Aztreonam in her study of Enterobacteriaceae. The various areas that Patricia A. Bradford examines in her Aztreonam study include Monobactam, Tigecycline, Colistin and Beta-Lactamase Inhibitors. Her Beta-lactamase research includes themes of Antibiotics and Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ceftriaxone-resistant salmonella infection acquired by a child from cattle.
Paul D. Fey;Thomas J. Safranek;Mark E. Rupp;Eileen F. Dunne.
The New England Journal of Medicine (2000)
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Janis Wiener;John P. Quinn;Patricia A. Bradford;Richard V. Goering.
Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City
Patricia A. Bradford;Simona Bratu;Carl Urban;Melissa Visalli.
Clinical Infectious Diseases (2004)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush;Patricia A. Bradford.
Cold Spring Harbor Perspectives in Medicine (2016)
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Charles R. Dean;Melissa A. Visalli;Steven J. Projan;Phaik-Eng Sum.
Antimicrobial Agents and Chemotherapy (2003)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
Peter J. Petersen;Ponpen Labthavikul;C. Hal Jones;Patricia A. Bradford.
Journal of Antimicrobial Chemotherapy (2006)
AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Alexey Ruzin;David Keeney;Patricia A. Bradford.
Journal of Antimicrobial Chemotherapy (2007)
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
Fionnuala McAleese;Peter Petersen;Alexey Ruzin;Paul M. Dunman.
Antimicrobial Agents and Chemotherapy (2005)
In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens
Peter J. Petersen;Patricia A. Bradford;William J. Weiss;Timothy M. Murphy.
Antimicrobial Agents and Chemotherapy (2002)
Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae
Alexey Ruzin;Melissa A. Visalli;David Keeney;Patricia A. Bradford.
Antimicrobial Agents and Chemotherapy (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: